1993430-24-2
1993430-24-2
Chemical Structure
Abiraterone sulfate N-oxide
- CAS No.: 1993430-24-2
- Formula:C24H31NO5S
- Molecular Weight:445.57
IUPAC Name: 3-((3S,8R,9S,10R,13S,14S)-10,13-dimethyl-3-(sulfooxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine 1-oxide
InChIKey: AEEMBGRHVQPUBV-VJLLXTKPSA-N
SMILES: C[C@@]12[C@](CC=C2C3=C[N+]([O-])=CC=C3)([H])[C@@]4([H])[C@@](CC1)([H])[C@@]5(C(C[C@H](CC5)OS(=O)(O)=O)=CC4)C
Biological Activity: Abiraterone sulfate N-oxide is a carboxylic acid. Abiraterone sulfate N-oxide also is a major metabolite of Abiraterone (HY-70013). Abiraterone sulfate N-oxide can be used for the research of prostate cancer[1][2].
| Cat. No. | 상품명 | Purity | 제품 설명 | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Abiraterone sulfate N-oxide | Abiraterone sulfate N-oxide is a carboxylic acid. Abiraterone sulfate N-oxide also is a major metabolite of Abiraterone (HY-70013). Abiraterone sulfate N-oxide can be used for the research of prostate cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Abiraterone sulfate N-oxide-d4 TEA | Abiraterone sulfate N-oxide-d4 TEA is the deuterium labeled Abiraterone sulfate N-oxide TEA (HY-148377). Abiraterone sulfate N-oxide is a carboxylic acid. Abiraterone sulfate N-oxide also is a major metabolite of Abiraterone (HY-70013). Abiraterone sulfate N-oxide can be used for the research of prostate cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Merel van Nuland, et al. Development and Validation of an LC-MS/MS Method for the Simultaneous Quantification of Abiraterone, Enzalutamide, and Their Major Metabolites in Human Plasma. Ther Drug Monit. 2017 Jun;39(3):243-251. [Content Brief]
- [2]. Johan Monbaliu, et al. In Vitro and In Vivo Drug-Drug Interaction Studies to Assess the Effect of Abiraterone Acetate, Abiraterone, and Metabolites of Abiraterone on CYP2C8 Activity. Drug Metab Dispos. 2016 Oct;44(10):1682-91. [Content Brief]
